FDA Halts Sarepta Shipments - Search News

Order byBest matchMost fresh

News

FDA, Sarepta and Gene therapy

· 2d · on MSN

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene therapy.

Continue reading

Sarepta under pressure: FDA requests halt of Elevidys shipments

· 2d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

11hon MSN

Sarepta extends losses premarket after refusing FDA’s halt request

Sarepta Therapeutics (SRPT) shares fell as much as 4.8% in premarket trading Monday, poised to extend losses for a second ...

8h

Sarepta Therapeutics: Why Is SRPT Stock Crashing?

The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results